The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Are The Forecasted Market Size Figures For The Travel Vaccines Market In 2026 And 2030?
The travel vaccines market size has experienced robust expansion in recent years. It is anticipated to expand from $5.09 billion in 2025 to $5.56 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.2%. This historical growth can be linked to several factors, including restricted access to vaccines in developing markets, inadequate public understanding of travel-related ailments, a reliance on conventional vaccination centers, regulatory authorizations for mono vaccines, and the sluggish integration of online booking platforms.
The travel vaccines market size is anticipated to undergo significant growth in the coming years. It is forecast to expand to $8.16 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.0%. This expansion during the forecast period can be attributed to factors like increasing global travel and mobility, advancements in biotechnology leading to combination vaccines, the development of digital health and telemedicine services, rising awareness regarding preventive healthcare, and the broadening of international travel immunization programs. Notable trends expected in this period include a rise in international tourism and business travel, increasing awareness among travelers about preventive healthcare, the expansion of online travel health services and booking platforms, the creation of combination and multivalent travel vaccines, and an increase in public-private partnerships for global immunization initiatives.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11918&type=smp
Which Strategic Drivers Are Supporting The Travel Vaccines Market Development?
The anticipated rise in travel and tourism is poised to drive the expansion of the travel vaccine market in the future. Travel and tourism encompass the movement of individuals or items, utilizing conveyances such as trains, boats, and airplanes, across diverse distant geographical regions. These vaccines play a crucial role in safeguarding the health and well-being of tourists and travelers during their international journeys. For example, UN Tourism, the Spain-based specialized agency dedicated to promoting responsible, sustainable, and universally accessible tourism, indicated in May 2025 that more than 300 million tourists journeyed internationally during the first three months of 2025. This figure represents an increase of approximately 14 million compared to the corresponding period in 2024, signifying a 5% year-on-year growth. Consequently, the escalating volume of travel and tourism is acting as a key catalyst for the growth of the travel vaccine market.
What Key Segment Areas Are Included In The Travel Vaccines Market Assessment?
The travel vaccines market covered in this report is segmented –
1) By Disease: Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,
2) By Composition: Mono Vaccines, Combination Vaccines
3) By Booking Channel: Online Booking, In-Person Booking
4) By Application: Domestic Travel, Outbound Travel
Which Trends Are Guiding The Development Of The Travel Vaccines Market?
Leading companies within the travel vaccine market are developing innovative vaccines to offer active immunization to prevent Hepatitis A, a common concern for travelers. A travel vaccine is an inoculation specifically designed to protect individuals from infectious diseases prevalent in certain regions or countries, often recommended for travelers visiting those areas. For instance, in January 2024, Indian Immunologicals Ltd. (IIL), an India-based biotechnology company, launched Havisure, India’s first indigenously developed Hepatitis A vaccine. Havisure is anticipated to be instrumental in providing protection against the Hepatitis A virus, which primarily impacts the liver. This vaccine is effective in preventing the disease and is advised for children as part of routine immunization. Additionally, it is recommended for individuals at risk of exposure or those traveling to areas with high rates of hepatitis A.
Which Companies Are Engaged In The Travel Vaccines Market Environment?
Major companies operating in the travel vaccines market are Pfizer Inc, Johnson and Johnson, Merck & Co. Inc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Serum Institute of India Pvt. Ltd., Bavarian Nordic A/S, Valneva SE, Panacea Biotec, Bharat Biotech International Limited, Bio Farma, Novavax Inc, Emergent BioSolutions UK, Biological E. Limited, Vabiotech, Cadila Healthcare Limited, Zydus Lifesciences Ltd, Cipla Inc, Haffkine Biopharmaceutical Corporation Ltd
Access The Complete Travel Vaccines Market Report:
https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report
Which Geographic Region Represents The Largest Travel Vaccines Market Share?
North America was the largest region in the travel vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the travel vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Travel Vaccines Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=11918&type=smp
Browse Through More Reports Similar to the Global Travel Vaccines Market 2026, By The Business Research Company
Travel Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report
Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report
Vaccine Delivery Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/vaccine-delivery-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model